Last update 02 Aug 2025

GT-719

Overview

Basic Info

Drug Type
TIL therapy
Synonyms
GT-719
Target
CD19
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
CD19 Expressing MalignanciesHematologic NeoplasmsAntibody-mediated rejection
Inactive Indication-
Originator Organization
Zhuhai Grit Biotechnology Co. Ltd.Zhuhai Grit Biotechnology Co. Ltd.
Active Organization
Zhuhai Grit Biotechnology Co. Ltd.Zhuhai Grit Biotechnology Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with GT-719
NCT06948981
/ RecruitingPhase 1/2
A Single-arm, Open-label, Phase I/II Clinical Study of GT719 Injection for Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
NCT07021209
/ RecruitingPhase 1
A Single-arm, Open-label, Phase I Clinical Study of GT719 Injection for Recurrent/Refractory Antibody Mediated Systemic Immune Diseases
100 Clinical Results associated with GT-719
Login to view more data
100 Translational Medicine associated with GT-719
Login to view more data
100 Patents (Medical) associated with GT-719
Login to view more data
100 Deals associated with GT-719
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD19 Expressing MalignanciesPhase 2
China
Zhuhai Grit Biotechnology Co. Ltd.Zhuhai Grit Biotechnology Co. Ltd.
18 Apr 2025
Hematologic NeoplasmsPhase 2
China
Zhuhai Grit Biotechnology Co. Ltd.Zhuhai Grit Biotechnology Co. Ltd.
18 Apr 2025
Antibody-mediated rejectionPhase 1
China
Zhuhai Grit Biotechnology Co. Ltd.Zhuhai Grit Biotechnology Co. Ltd.
14 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free